Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CONNECT WITH ME

Kristijan Ramadan

Professor of Molecular Medicine

  • Honorary Senior Researcher - Department of Oncology, University of Oxford
  • Medical Research Council (MRC) Investigator
  • Corresponding Member of the Croatian Academy of Sciences and Arts

Biography

Kristijan holds degrees in Veterinary Medicine (DVM), Veterinary Pathology (MSc) and PhD in Biochemistry and Molecular Biology under supervision of Prof. Dr. U. Hübscher. He did his post-doctoral training at the ETH-Zürich in the group of Dr H. Meyer. Between 2009 and 2013 he was Junior Group Leader and Lecturer at the Institute of Pharmacology and Toxicology-Vetsuisse, University of Zürich. In 2013 he moved to the UK to join the Department of Oncology as MRC Senior Group leader. From 2014 to 2019 he was Associate Professor at the Department of Oncology, University of Oxford. In 2019 Kristijan was promoted to the Full Professor of Molecular Medicine at University of Oxford.

Kristijan received the Proud of Croatia Award (Croatian Hero for 2014) for his scientific contribution in saving the life of a young boy who suffered from liver cancer caused by mutations in the SPRTN gene.

His work contributed to the discoveries of Chromatin-Associated Degradation, DNA-protein crosslink proteolysis repair and Ruijs-Aalfs Syndrome (RJALS). 

In 2020 Kristijan was elected to the Croatian Academy of Sciences and Arts (HAZU) as a distinguished scientist in the field of Medicine.

Key publications

Charting New Paths in Cancer Research: Insights from the Frontiers in Cancer Science Conference 2024.

Journal article

Le Minh G. et al, (2025), Cancer Res, 85, 2784 - 2787

The NUCKS1-SKP2-p21/p27 axis controls S phase entry.

Journal article

Hume S. et al, (2021), Nat Commun, 12

A unified model for the G1/S cell cycle transition.

Journal article

Hume S. et al, (2020), Nucleic Acids Res, 48, 12483 - 12501

Inhibition of mammalian DNA polymerases by resveratrol: mechanism and structural determinants.

Journal article

Locatelli GA. et al, (2005), Biochem J, 389, 259 - 268

Recent publications

Nucleophagy as an emerging therapeutic vulnerability in cancer.

Journal article

Tribble S. and Ramadan K., (2026), Autophagy, 1 - 3

Nucleophagy removes cytotoxic trapped PARP1.

Journal article

Hoslett G. et al, (2026), Nat Cell Biol

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

Journal article

Phyu SM. et al, (2026), Curr Opin Cell Biol, 99

More publications